Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lisdexamfetamine Dimesylate bulk supplier for pharma manufacturers

Lisdexamfetamine Dimesylate Suppliers & Bulk Manufacturers

Available Forms: Tablets, Capsules

Available Strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Reference Brands: Vyvanse (USA)

Category: Neurology

Lisdexamfetamine Dimesylate is a Neurology product available as Tablets, Capsules in strengths 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg. It corresponds to the reference brand Vyvanse (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Lisdexamfetamine dimesylate is a central nervous system stimulant used primarily for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also approved for the management of moderate-to-severe binge eating disorder in adults. As a prodrug of dextroamphetamine, lisdexamfetamine is converted to its active form in the body, allowing for a gradual onset of action and sustained therapeutic effects. This mechanism helps reduce the potential for abuse compared to immediate-release amphetamines and supports consistent symptom control over the day.

Lisdexamfetamine helps improve focus, attention, and impulse control in individuals with ADHD, while also reducing binge-eating episodes in adults with binge eating disorder. It is administered orally and is available in capsule, chewable tablet, and oral solution formulations, depending on patient needs. Off-label uses are similar to other pharmaceutical amphetamines, including the treatment of narcolepsy. Clinical studies have demonstrated its effectiveness in adults, with lisdexamfetamine recognized as one of the most effective treatments for adult ADHD. Its use requires medical supervision to monitor efficacy, dosing, and potential side effects.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Lisdexamfetamine dimesylate is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also indicated for the management of moderate to severe binge eating disorder in adults in select regions.


Lisdexamfetamine dimesylate is a chemically synthesized prodrug of dextroamphetamine formulated for oral administration in capsules, chewable tablets, or oral solution.


The trade names include Vyvanse in the USA and Elvanse in Europe and the UK.


It is developed and marketed by Shire Pharmaceuticals, now part of Takeda Pharmaceutical Company, globally.


The generic name is lisdexamfetamine dimesylate.


The brand names are Vyvanse and Elvanse.


Lisdexamfetamine dimesylate is manufactured in FDA-, EMA-, and MHRA-approved facilities, adhering to international pharmaceutical quality standards.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.